Works by Jin, Jin Y

Results: 53

A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer.
Published in:
Biopharmaceutics & Drug Disposition, 2013, v. 34, n. 3, p. 141, doi. 10.1002/bdd.1830
By:
- Cheeti, Sravanthi;
- Budha, Nageshwar R.;
- Rajan, Sharmila;
- Dresser, Mark J.;
- Jin, Jin Y.
Publication type:
Article
Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
Published in:
Biopharmaceutics & Drug Disposition, 2012, v. 33, n. 2, p. 85, doi. 10.1002/bdd.1769
By:
- Chen, Yuan;
- Jin, Jin Y.;
- Mukadam, Sophie;
- Malhi, Vikram;
- Kenny, Jane R.
Publication type:
Article
Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models.
Published in:
British Journal of Cancer, 2023, v. 129, n. 9, p. 1383, doi. 10.1038/s41416-023-02190-5
By:
- Bruno, René;
- Chanu, Pascal;
- Kågedal, Matts;
- Mercier, Francois;
- Yoshida, Kenta;
- Guedj, Jérémie;
- Li, Chunze;
- Beyer, Ulrich;
- Jin, Jin Y.
Publication type:
Article
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease.
Published in:
Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-0580-2
By:
- Yoshida, Kenta;
- Moein, Anita;
- Bittner, Tobias;
- Ostrowitzki, Susanne;
- Lin, Helen;
- Honigberg, Lee;
- Jin, Jin Y.;
- Quartino, Angelica
Publication type:
Article
Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancer
Published in:
Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 3, p. 421, doi. 10.1007/s00280-024-04690-4
By:
- Moein, Anita;
- Jin, Jin Y.;
- Wright, Matthew R.;
- Wong, Harvey
Publication type:
Article
Combining 'Bottom-up' and 'Top-down' Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC-0941) Pharmacokinetics.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 11, p. 747, doi. 10.1002/psp4.12228
By:
- Lu, Tong;
- Fraczkiewicz, Grazyna;
- Salphati, Laurent;
- Budha, Nageshwar;
- Dalziel, Gena;
- Smelick, Gillian S.;
- Morrissey, Kari M.;
- Davis, John D.;
- Jin, Jin Y.;
- Ware, Joseph A.
Publication type:
Article
Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.
Published in:
Journal of Clinical Pharmacology, 2016, v. 56, n. 7, p. 835, doi. 10.1002/jcph.668
By:
- Wang, Yehong;
- Zhu, Rui;
- Xiao, Jim;
- Davis, John C.;
- Mandema, Jaap W.;
- Jin, Jin Y.;
- Tang, Meina T.
Publication type:
Article
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score.
Published in:
CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2310, doi. 10.1111/cts.13632
By:
- Moein, Anita;
- Langenhorst, Jurgen;
- Plan, Elodie L.;
- Jin, Jin Y.;
- Kågedal, Matts;
- Kassir, Nastya
Publication type:
Article
Systems‐based digital twins to help characterize clinical dose–response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL.
Published in:
CTS: Clinical & Translational Science, 2023, v. 16, n. 7, p. 1134, doi. 10.1111/cts.13501
By:
- Susilo, Monica E.;
- Li, Chi‐Chung;
- Gadkar, Kapil;
- Hernandez, Genevive;
- Huw, Ling‐Yuh;
- Jin, Jin Y.;
- Yin, Shen;
- Wei, Michael C.;
- Ramanujan, Saroja;
- Hosseini, Iraj
Publication type:
Article
Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology.
Published in:
2018
By:
- Ji, Yan;
- Jin, Jin Y.;
- Hyman, David M.;
- Kim, Geoffrey;
- Suri, Ajit
Publication type:
Proceeding
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two‐stage approaches.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 6, p. 1017, doi. 10.1002/psp4.13137
By:
- Marchand, Mathilde;
- Gonçalves, Antonio;
- Mercier, François;
- Chanu, Pascal;
- Jin, Jin Y.;
- Guedj, Jérémie;
- Bruno, René
Publication type:
Article
Deep‐NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 5, p. 870, doi. 10.1002/psp4.13124
By:
- Liu, Gengbo;
- Brooks, Logan;
- Canty, John;
- Lu, Dan;
- Jin, Jin Y.;
- Lu, James
Publication type:
Article
gPKPDviz: A flexible R shiny tool for pharmacokinetic/pharmacodynamic simulations using mrgsolve.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 3, p. 341, doi. 10.1002/psp4.13096
By:
- Lu, Tong;
- Poon, Victor;
- Brooks, Logan;
- Velasquez, Erick;
- Anderson, Eric;
- Baron, Kyle;
- Jin, Jin Y.;
- Kågedal, Matts
Publication type:
Article
Comparison of two‐stage and joint TGI‐OS modeling using data from six atezolizumab clinical studies in patients with metastatic non‐small cell lung cancer.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 1, p. 68, doi. 10.1002/psp4.13057
By:
- Gonçalves, Antonio;
- Marchand, Mathilde;
- Chan, Phyllis;
- Jin, Jin Y.;
- Guedj, Jérémie;
- Bruno, René
Publication type:
Article
Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 7, p. 1029, doi. 10.1002/psp4.12974
By:
- Jamalian, Samira;
- Dolton, Michael;
- Chanu, Pascal;
- Ramakrishnan, Vidya;
- Franco, Yesenia;
- Wildsmith, Kristin;
- Manser, Paul;
- Teng, Edmond;
- Jin, Jin Y.;
- Quartino, Angelica;
- Hsu, Joy C.
Publication type:
Article
Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 7, p. 883, doi. 10.1002/psp4.12970
By:
- Schmidt, Stephan;
- Vozmediano, Valvanera;
- Cristofoletti, Rodrigo;
- Kim, Sarah;
- Lin, Zhoumeng;
- de Moraes, Natalia;
- Azeredo, Francine;
- Cicali, Brian;
- Leuenberger, Hans;
- Brown, Joshua D.;
- Jin, Jin Y.;
- Musante, Cynthia J.;
- Tannenbaum, Stacey;
- Wang, Yaning
Publication type:
Article
Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 1, p. 62, doi. 10.1002/psp4.12876
By:
- Ramakrishnan, Vidya;
- Friedrich, Christina;
- Witt, Colleen;
- Sheehan, Robert;
- Pryor, Meghan;
- Atwal, Jasvinder K.;
- Wildsmith, Kristin;
- Kudrycki, Katherine;
- Lee, Seung‐Hye;
- Mazer, Norman;
- Hofmann, Carsten;
- Fuji, Reina N.;
- Jin, Jin Y.;
- Ramanujan, Saroja;
- Dolton, Michael;
- Quartino, Angelica
Publication type:
Article
Update to improve reproducibility and interpretability: A response to "Machine Learning for Tumor Growth Inhibition".
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 3, p. 262, doi. 10.1002/psp4.12760
By:
- Chan, Phyllis;
- Lu, James;
- Bruno, René;
- Jin, Jin Y.
Publication type:
Article
Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1255, doi. 10.1002/psp4.12693
By:
- Krishnan, Sreenath M.;
- Friberg, Lena E.;
- Bruno, René;
- Beyer, Ulrich;
- Jin, Jin Y.;
- Karlsson, Mats O.
Publication type:
Article
Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1171, doi. 10.1002/psp4.12686
By:
- Chan, Phyllis;
- Marchand, Mathilde;
- Yoshida, Kenta;
- Vadhavkar, Shweta;
- Wang, Nina;
- Lin, Alyse;
- Wu, Benjamin;
- Ballinger, Marcus;
- Sternheim, Nitzan;
- Jin, Jin Y.;
- Bruno, René
Publication type:
Article
Application of Machine Learning for Tumor Growth Inhibition – Overall Survival Modeling Platform.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 1, p. 59, doi. 10.1002/psp4.12576
By:
- Chan, Phyllis;
- Zhou, Xiaofei;
- Wang, Nina;
- Liu, Qi;
- Bruno, René;
- Jin, Jin Y.
Publication type:
Article
Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow‐Up Time.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 2, p. 115, doi. 10.1002/psp4.12489
By:
- Netterberg, Ida;
- Bruno, René;
- Chen, Ya‐Chi;
- Winter, Helen;
- Li, Chi‐Chung;
- Jin, Jin Y.;
- Friberg, Lena E.
Publication type:
Article
Analysis of Longitudinal‐Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 2, p. 96, doi. 10.1002/psp4.12487
By:
- Lu, Tong;
- Yang, Yujie;
- Jin, Jin Y.;
- Kågedal, Matts
Publication type:
Article
Time‐to‐Event Modeling of Peripheral Neuropathy: Platform Analysis of Eight Valine‐Citrulline‐Monomethylauristatin E Antibody–Drug Conjugates.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 8, p. 606, doi. 10.1002/psp4.12442
By:
- Kågedal, Matts;
- Samineni, Divya;
- Gillespie, William R.;
- Lu, Dan;
- Fine, Bernard M.;
- Girish, Sandhya;
- Li, Chunze;
- Jin, Jin Y.
Publication type:
Article
Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.974423
By:
- Weize Huang;
- Stader, Felix;
- Chan, Phyllis;
- Shemesh, Colby S.;
- Yuan Chen;
- Gill, Katherine L.;
- Jones, Hannah M.;
- Linzhong Li;
- Rossato, Gianluca;
- Wu, Benjamin;
- Jin Y. Jin;
- Chanu, Pascal
Publication type:
Article
Evaluation of Cytochrome P450 3A4-Mediated Drug-Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation.
Published in:
2016
By:
- Budha, Nageshwar;
- Ji, Tao;
- Musib, Luna;
- Eppler, Steve;
- Dresser, Mark;
- Chen, Yuan;
- Jin, Jin;
- Budha, Nageshwar R;
- Jin, Jin Y
Publication type:
journal article
Assessment of cytochrome P450 3A4-mediated drug–drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model.
Published in:
Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 5, p. 707, doi. 10.1007/s00280-022-04434-2
By:
- Jing, Jing;
- Chen, Yuan;
- Musib, Luna;
- Jin, Jin Y.;
- Cheung, Kit Wun Kathy;
- Yoshida, Kenta;
- Sane, Rucha
Publication type:
Article
Time-dependent population PK models of single-agent atezolizumab in patients with cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 2, p. 211, doi. 10.1007/s00280-021-04276-4
By:
- Marchand, Mathilde;
- Zhang, Rong;
- Chan, Phyllis;
- Quarmby, Valerie;
- Ballinger, Marcus;
- Sternheim, Nitzan;
- Wu, Benjamin;
- Jin, Jin Y.;
- Bruno, René
Publication type:
Article
Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma.
Published in:
2020
By:
- Shemesh, Colby S.;
- Agarwal, Priya;
- Lu, Tong;
- Lee, Calvin;
- Dere, Randall C.;
- Li, Xiaobin;
- Li, Chunze;
- Jin, Jin Y.;
- Girish, Sandhya;
- Miles, Dale;
- Lu, Dan
Publication type:
journal article
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting.
Published in:
2019
By:
- Morrissey, Kari M.;
- Marchand, Mathilde;
- Patel, Hina;
- Zhang, Rong;
- Wu, Benjamin;
- Phyllis Chan, H.;
- Mecke, Almut;
- Girish, Sandhya;
- Jin, Jin Y.;
- Winter, Helen R.;
- Bruno, René
Publication type:
journal article
Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin<sup>®</sup>), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors.
Published in:
2019
By:
- Quartino, Angelica L.;
- Li, Hanbin;
- Kirschbrown, Whitney P.;
- Mangat, Ranvir;
- Wada, D. Russell;
- Garg, Amit;
- Jin, Jin Y.;
- Lum, Bert
Publication type:
journal article
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer.
Published in:
2017
By:
- Quartino, Angelica;
- Li, Hanbin;
- Jin, Jin;
- Wada, D.;
- Benyunes, Mark;
- McNally, Virginia;
- Viganò, Lucia;
- Nijem, Ihsan;
- Lum, Bert;
- Garg, Amit;
- Quartino, Angelica L;
- Jin, Jin Y;
- Wada, D Russell;
- Benyunes, Mark C;
- Viganò, Lucia;
- Lum, Bert L
Publication type:
journal article
Ethnic sensitivity assessment of the antibody-drug conjugate trastuzumab emtansine (T-DM1) in patients with HER2-positive locally advanced or metastatic breast cancer.
Published in:
2016
By:
- Li, Chunze;
- Wang, Bei;
- Lu, Dan;
- Jin, Jin;
- Gao, Yuying;
- Matsunaga, Kiyoshi;
- Igawa, Yuriko;
- Nijem, Ihsan;
- Lu, Michael;
- Strasak, Alexander;
- Chernyukhin, Nataliya;
- Girish, Sandhya;
- Jin, Jin Y
Publication type:
journal article
Population pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous "manual syringe" injection or intravenously in women with HER2-positive early breast cancer.
Published in:
2016
By:
- Quartino, Angelica;
- Hillenbach, Carina;
- Li, Jing;
- Li, Hanbin;
- Wada, Russell;
- Visich, Jennifer;
- Li, Chunze;
- Heinzmann, Dominik;
- Jin, Jin;
- Lum, Bert;
- Quartino, Angelica L;
- Wada, Russell D;
- Jin, Jin Y;
- Lum, Bert L
Publication type:
journal article
Population pharmacokinetics and dosing implications for cobimetinib in patients with solid tumors.
Published in:
2015
By:
- Han, Kelong;
- Jin, Jin;
- Marchand, Mathilde;
- Eppler, Stephen;
- Choong, Nicholas;
- Hack, Stephen;
- Tikoo, Nalin;
- Bruno, Rene;
- Dresser, Mark;
- Musib, Luna;
- Budha, Nageshwar;
- Jin, Jin Y;
- Hack, Stephen P;
- Budha, Nageshwar R
Publication type:
journal article
Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor.
Published in:
Drugs in R&D, 2024, v. 24, n. 2, p. 155, doi. 10.1007/s40268-024-00459-5
By:
- Moein, Anita;
- Jin, Jin Y.;
- Wright, Matthew R.;
- Alicke, Bruno;
- Wong, Harvey
Publication type:
Article
Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure‐Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor)
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 9, p. 1101, doi. 10.1002/jcph.2444
By:
- Moein, Anita;
- Jin, Jin Y.;
- Wright, Matthew R.;
- Wong, Harvey
Publication type:
Article
Population Pharmacokinetics of Ranibizumab Delivered via the Port Delivery System Implanted in the Eye in Patients with Neovascular Age‐Related Macular Degeneration.
Published in:
Journal of Clinical Pharmacology, 2023, v. 63, n. 11, p. 1210, doi. 10.1002/jcph.2290
By:
- Kågedal, Matts;
- Alskär, Oskar;
- Petersson, Klas;
- Hanze, Eva;
- Maia, Mauricio;
- Lu, Tong;
- Vakhavkar, Shweta;
- Quartino, Angelica;
- Willis, Jeffrey R.;
- Jin, Jin Y.;
- Maass, Katie F.
Publication type:
Article
Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics.
Published in:
Journal of Clinical Pharmacology, 2021, v. 61, n. 8, p. 1096, doi. 10.1002/jcph.1855
By:
- Liu, Stephanie N.;
- Lu, Tong;
- Jin, Jin Y.;
- Li, Chunze;
- Girish, Sandhya;
- Melnikov, Fjodor;
- Badovinac Crnjevic, Tanja;
- Machackova, Zuzana;
- Restuccia, Eleonora;
- Kirschbrown, Whitney P.
Publication type:
Article
Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates.
Published in:
Journal of Clinical Pharmacology, 2020, v. 60, p. S105, doi. 10.1002/jcph.1720
By:
- Li, Chunze;
- Chen, Shang‐Chiung;
- Chen, Yuan;
- Girish, Sandhya;
- Kågedal, Matts;
- Lu, Dan;
- Lu, Tong;
- Samineni, Divya;
- Jin, Jin Y.
Publication type:
Article
Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody‐Drug Conjugates.
Published in:
Journal of Clinical Pharmacology, 2020, v. 60, p. S105, doi. 10.1002/jcph.1720
By:
- Li, Chunze;
- Chen, Shang‐Chiung;
- Chen, Yuan;
- Girish, Sandhya;
- Kaagedal, Matts;
- Lu, Dan;
- Lu, Tong;
- Samineni, Divya;
- Jin, Jin Y.
Publication type:
Article
Tumor Growth Inhibition-Overall Survival (TGI-OS) Model for Subgroup Analysis Based on Post-Randomization Factors: Application for Anti-drug Antibody (ADA) Subgroup Analysis of Atezolizumab in the IMpower150 Study.
Published in:
AAPS Journal, 2022, v. 24, n. 3, p. 1, doi. 10.1208/s12248-022-00710-4
By:
- Yoshida, Kenta;
- Chan, Phyllis;
- Marchand, Mathilde;
- Zhang, Rong;
- Wu, Benjamin;
- Ballinger, Marcus;
- Sternheim, Nitzan;
- Jin, Jin Y.;
- Bruno, René
Publication type:
Article
A Physiologically Based Pharmacokinetic Model of Vismodegib: Deconvoluting the Impact of Saturable Plasma Protein Binding, pH-Dependent Solubility and Nonsink Permeation.
Published in:
AAPS Journal, 2020, v. 22, n. 5, p. 1, doi. 10.1208/s12248-020-00503-7
By:
- Dolton, Michael J.;
- Chiang, Po-Chang;
- Ma, Fang;
- Jin, Jin Y.;
- Chen, Yuan
Publication type:
Article
A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response Theory.
Published in:
Pharmaceutical Research, 2018, v. 35, n. 6, p. 1, doi. 10.1007/s11095-018-2403-8
By:
- Schindler, Emilie;
- Friberg, Lena E.;
- Lum, Bertram L.;
- Bei Wang;
- Quartino, Angelica;
- Chunze Li;
- Girish, Sandhya;
- Jin, Jin Y.;
- Karlsson, Mats O.
Publication type:
Article
Nonlinear multilevel joint model for individual lesion kinetics and survival to characterize intra‐individual heterogeneity in patients with advanced cancer.
Published in:
Biometrics, 2023, v. 79, n. 4, p. 3752, doi. 10.1111/biom.13912
By:
- Kerioui, Marion;
- Beaulieu, Maxime;
- Desmée, Solène;
- Bertrand, Julie;
- Mercier, François;
- Jin, Jin Y.;
- Bruno, René;
- Guedj, Jérémie
Publication type:
Article
Applications of Advanced Natural Language Processing for Clinical Pharmacology.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 786, doi. 10.1002/cpt.3161
By:
- Hsu, Joy C.;
- Wu, Michael;
- Kim, Chloe;
- Vora, Bianca;
- Lien, Yi Ting;
- Jindal, Ashutosh;
- Yoshida, Kenta;
- Kawakatsu, Sonoko;
- Gore, Jeremy;
- Jin, Jin Y.;
- Lu, Christina;
- Chen, Bingyuan;
- Wu, Benjamin
Publication type:
Article
Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 698, doi. 10.1002/cpt.3083
By:
- Shahin, Mohamed H.;
- Barth, Aline;
- Podichetty, Jagdeep T.;
- Liu, Qi;
- Goyal, Navin;
- Jin, Jin Y.;
- Ouellet, Daniele
Publication type:
Article
Challenging the Norm: A Multidisciplinary Perspective on Intravenous to Subcutaneous Bridging Strategies for Biologics.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 412, doi. 10.1002/cpt.3133
By:
- Ait‐Oudhia, Sihem;
- Wang, Yow‐Ming;
- Dosne, Anne‐Gaelle;
- Roy, Amit;
- Jin, Jin Y.;
- Shen, Jun;
- Kagan, Leonid;
- Musuamba, Flora T.;
- Zhang, Lucia;
- Kijima, Shinichi;
- Gastonguay, Marc R.;
- Ouellet, Daniele
Publication type:
Article
Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition‐Survival Modeling Framework.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 644, doi. 10.1002/cpt.2953
By:
- Shemesh, Colby S.;
- Chan, Phyllis;
- Marchand, Mathilde;
- Gonçalves, Antonio;
- Vadhavkar, Shweta;
- Wu, Benjamin;
- Li, Chunze;
- Jin, Jin Y.;
- Hack, Stephen P.;
- Bruno, Rene
Publication type:
Article
Opportunities and Challenges of Disease Progression Modeling in Drug Development – An IQ Perspective.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 266, doi. 10.1002/cpt.2873
By:
- Goteti, Kosalaram;
- Hanan, Nathan;
- Magee, Mindy;
- Wojciechowski, Jessica;
- Mensing, Sven;
- Lalovic, Bojan;
- Hang, Yaming;
- Solms, Alexander;
- Singh, Indrajeet;
- Singh, Rajendra;
- Rieger, Theodore Robert;
- Jin, Jin Y.
Publication type:
Article